L858R Mutation in Circulating Free DNA Is Prognostic in NSCLC
L858R mutation in tumor tissue or cfDNA is marker of shorter overall, progression-free survival
Hospital Design Has Little Effect on Patient Satisfaction
Aesthetics aren't as important as care from doctors, nurses, and staff, researchers note
Genitourinary Cancers Symposium, Feb. 26-28
The 2015 Genitourinary Cancers Symposium The American Society of Clinical Oncology's annual Genitourinary Cancers Symposium was held from Feb. 26 to 28 in...
Genetic Mutations Found in Leukemia Rise With Age
But just having cancer-linked DNA doesn't mean the disease will develop, study authors stress
AMA: Key Steps for Minimizing Liability Risk in Telemedicine
Include defining minimum requirement necessary for establishing doctor-patient relationship
Oral Bisphosphonate Use Tied to Lower Endometrial Cancer Risk
Reduction in endometrial cancer risk with ever use in large cohort of postmenopausal women
Researchers Examine Etiology of Ibrutinib Discontinuation in CLL
Poor prognosis after discontinuation for disease progression, especially Richter's transformation
ASCO: High-Risk Prostate Cancer Diagnosis Up Since New PSA Recs
Researchers report 3 percent annual rise in intermediate- and high-risk cases
Location of Colorectal Cancer Factors Into Survival
Poorer outcome seen in study when tumor began on the organ's right side
Suicide Deemed Public Health Concern in Genitourinary Cancers
Risk factors include male gender, distant disease, increasing age, race/ethnicity
